Chinese companies exporting drugs in bulk will come under the microscope next month when the Indian government sends a team of officials to inspect manufacturing plants.
The news follows a letter from India’s Central Drug Standard Control Organization (CDSCO) to the Chinese Food and Drug Authority (SFDA) querying complaints that some exporters did not hold GMP (good manufacturing practice) certificates.
An official from the Union Health Ministry told Times of India the SFDA also held suspicions, and requested CDSCO carry out some inspections.
Those reportedly coming under fire include SouthWest Synthetic Pharmaceutical Corporation in Chongqing, Suzhou Dawnrays Pharmaceuticals in Jiangsu Province, and InTec Products in Fujian Province.
More than 45% of bulk drug exporters registered in India are from China.